Nutrient-induced glucagon like peptide-1 release is modulated by serotonin (2024)

Abstract

Glucagon like peptide-1 (GLP-1) and serotonin are both involved in food intake regulation. GLP-1 release is stimulated upon nutrient interaction with G-protein coupled receptors by enteroendocrine cells (EEC), whereas serotonin is released from enterochromaffin cells (ECC). The central hypothesis for the current study was that nutrient-induced GLP-1 release from EECs is modulated by serotonin through a process involving serotonin receptor interaction. This was studied by assessing the effects of serotonin reuptake inhibition by fluoxetine on nutrient-induced GLP-1, PYY and CCK release from isolated pig intestinal segments. Next, serotonin-induced GLP-1 release was studied in enteroendocrine STC-1 cells, where effects of serotonin receptor inhibition were studied using specific and non-specific antagonists.Casein (1% w/v), safflower oil (3.35% w/v), sucrose (50 mM) and rebaudioside A (12.5 mM) stimulated GLP-1 release from intestinal segments, whereas casein only stimulated PYY and CCK release. Combining nutrients with fluoxetine further increased nutrient-induced GLP-1, PYY and CCK release.Serotonin release from intestinal tissue segments was stimulated by casein and safflower oil while sucrose and rebaudioside A had no effect. The combination with fluoxetine (0.155 μM) further enhanced casein and safflower oil induced-serotonin release.Exposure of ileal tissue segments to serotonin (30 μM) stimulated GLP-1 release whereas it did not induce PYY and CCK release. Serotonin (30 and 100 μM) also stimulated GLP-1 release from STC-1 cells, which was inhibited by the non-specific 5HT receptor antagonist asenapine (1 and 10 μM). These data suggest that nutrient-induced GLP-1 release is modulated by serotonin through a receptor mediated process.

Original languageEnglish
Pages (from-to)142-150
JournalJournal of Nutritional Biochemistry
Volume32
DOIs
Publication statusPublished - 2016

Keywords

  • GLP-1
  • Nutrients
  • Rebaudioside A
  • Serotonin
  • Small intestine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • Nutrient-induced glucagon like peptide-1 release is modulated by serotonin (1)

Access to Document

Fingerprint

Dive into the research topics of 'Nutrient-induced glucagon like peptide-1 release is modulated by serotonin'. Together they form a unique fingerprint.

Cite this

  • APA
  • Author
  • BIBTEX
  • Harvard
  • Standard
  • RIS
  • Vancouver

Ripken, D., van der Wielen, N., Wortelboer, H. M., Meijerink, J., Witkamp, R. F., & Hendriks, H. F. J. (2016). Nutrient-induced glucagon like peptide-1 release is modulated by serotonin. Journal of Nutritional Biochemistry, 32, 142-150. https://doi.org/10.1016/j.jnutbio.2016.03.006

Ripken, Dina ; van der Wielen, Nikkie ; Wortelboer, Heleen M. et al. / Nutrient-induced glucagon like peptide-1 release is modulated by serotonin. In: Journal of Nutritional Biochemistry. 2016 ; Vol. 32. pp. 142-150.

@article{f981ae20fd384f5b9e0cd6522d62c4ed,

title = "Nutrient-induced glucagon like peptide-1 release is modulated by serotonin",

abstract = "Glucagon like peptide-1 (GLP-1) and serotonin are both involved in food intake regulation. GLP-1 release is stimulated upon nutrient interaction with G-protein coupled receptors by enteroendocrine cells (EEC), whereas serotonin is released from enterochromaffin cells (ECC). The central hypothesis for the current study was that nutrient-induced GLP-1 release from EECs is modulated by serotonin through a process involving serotonin receptor interaction. This was studied by assessing the effects of serotonin reuptake inhibition by fluoxetine on nutrient-induced GLP-1, PYY and CCK release from isolated pig intestinal segments. Next, serotonin-induced GLP-1 release was studied in enteroendocrine STC-1 cells, where effects of serotonin receptor inhibition were studied using specific and non-specific antagonists.Casein (1% w/v), safflower oil (3.35% w/v), sucrose (50 mM) and rebaudioside A (12.5 mM) stimulated GLP-1 release from intestinal segments, whereas casein only stimulated PYY and CCK release. Combining nutrients with fluoxetine further increased nutrient-induced GLP-1, PYY and CCK release.Serotonin release from intestinal tissue segments was stimulated by casein and safflower oil while sucrose and rebaudioside A had no effect. The combination with fluoxetine (0.155 μM) further enhanced casein and safflower oil induced-serotonin release.Exposure of ileal tissue segments to serotonin (30 μM) stimulated GLP-1 release whereas it did not induce PYY and CCK release. Serotonin (30 and 100 μM) also stimulated GLP-1 release from STC-1 cells, which was inhibited by the non-specific 5HT receptor antagonist asenapine (1 and 10 μM). These data suggest that nutrient-induced GLP-1 release is modulated by serotonin through a receptor mediated process.",

keywords = "GLP-1, Nutrients, Rebaudioside A, Serotonin, Small intestine",

author = "Dina Ripken and {van der Wielen}, Nikkie and Wortelboer, {Heleen M.} and Jocelijn Meijerink and Witkamp, {Renger F.} and Hendriks, {Henk F.J.}",

year = "2016",

doi = "10.1016/j.jnutbio.2016.03.006",

language = "English",

volume = "32",

pages = "142--150",

journal = "Journal of Nutritional Biochemistry",

issn = "0955-2863",

publisher = "Elsevier",

}

Ripken, D, van der Wielen, N, Wortelboer, HM, Meijerink, J, Witkamp, RF & Hendriks, HFJ 2016, 'Nutrient-induced glucagon like peptide-1 release is modulated by serotonin', Journal of Nutritional Biochemistry, vol. 32, pp. 142-150. https://doi.org/10.1016/j.jnutbio.2016.03.006

Nutrient-induced glucagon like peptide-1 release is modulated by serotonin. / Ripken, Dina; van der Wielen, Nikkie; Wortelboer, Heleen M. et al.
In: Journal of Nutritional Biochemistry, Vol. 32, 2016, p. 142-150.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Nutrient-induced glucagon like peptide-1 release is modulated by serotonin

AU - Ripken, Dina

AU - van der Wielen, Nikkie

AU - Wortelboer, Heleen M.

AU - Meijerink, Jocelijn

AU - Witkamp, Renger F.

AU - Hendriks, Henk F.J.

PY - 2016

Y1 - 2016

N2 - Glucagon like peptide-1 (GLP-1) and serotonin are both involved in food intake regulation. GLP-1 release is stimulated upon nutrient interaction with G-protein coupled receptors by enteroendocrine cells (EEC), whereas serotonin is released from enterochromaffin cells (ECC). The central hypothesis for the current study was that nutrient-induced GLP-1 release from EECs is modulated by serotonin through a process involving serotonin receptor interaction. This was studied by assessing the effects of serotonin reuptake inhibition by fluoxetine on nutrient-induced GLP-1, PYY and CCK release from isolated pig intestinal segments. Next, serotonin-induced GLP-1 release was studied in enteroendocrine STC-1 cells, where effects of serotonin receptor inhibition were studied using specific and non-specific antagonists.Casein (1% w/v), safflower oil (3.35% w/v), sucrose (50 mM) and rebaudioside A (12.5 mM) stimulated GLP-1 release from intestinal segments, whereas casein only stimulated PYY and CCK release. Combining nutrients with fluoxetine further increased nutrient-induced GLP-1, PYY and CCK release.Serotonin release from intestinal tissue segments was stimulated by casein and safflower oil while sucrose and rebaudioside A had no effect. The combination with fluoxetine (0.155 μM) further enhanced casein and safflower oil induced-serotonin release.Exposure of ileal tissue segments to serotonin (30 μM) stimulated GLP-1 release whereas it did not induce PYY and CCK release. Serotonin (30 and 100 μM) also stimulated GLP-1 release from STC-1 cells, which was inhibited by the non-specific 5HT receptor antagonist asenapine (1 and 10 μM). These data suggest that nutrient-induced GLP-1 release is modulated by serotonin through a receptor mediated process.

AB - Glucagon like peptide-1 (GLP-1) and serotonin are both involved in food intake regulation. GLP-1 release is stimulated upon nutrient interaction with G-protein coupled receptors by enteroendocrine cells (EEC), whereas serotonin is released from enterochromaffin cells (ECC). The central hypothesis for the current study was that nutrient-induced GLP-1 release from EECs is modulated by serotonin through a process involving serotonin receptor interaction. This was studied by assessing the effects of serotonin reuptake inhibition by fluoxetine on nutrient-induced GLP-1, PYY and CCK release from isolated pig intestinal segments. Next, serotonin-induced GLP-1 release was studied in enteroendocrine STC-1 cells, where effects of serotonin receptor inhibition were studied using specific and non-specific antagonists.Casein (1% w/v), safflower oil (3.35% w/v), sucrose (50 mM) and rebaudioside A (12.5 mM) stimulated GLP-1 release from intestinal segments, whereas casein only stimulated PYY and CCK release. Combining nutrients with fluoxetine further increased nutrient-induced GLP-1, PYY and CCK release.Serotonin release from intestinal tissue segments was stimulated by casein and safflower oil while sucrose and rebaudioside A had no effect. The combination with fluoxetine (0.155 μM) further enhanced casein and safflower oil induced-serotonin release.Exposure of ileal tissue segments to serotonin (30 μM) stimulated GLP-1 release whereas it did not induce PYY and CCK release. Serotonin (30 and 100 μM) also stimulated GLP-1 release from STC-1 cells, which was inhibited by the non-specific 5HT receptor antagonist asenapine (1 and 10 μM). These data suggest that nutrient-induced GLP-1 release is modulated by serotonin through a receptor mediated process.

KW - GLP-1

KW - Nutrients

KW - Rebaudioside A

KW - Serotonin

KW - Small intestine

U2 - 10.1016/j.jnutbio.2016.03.006

DO - 10.1016/j.jnutbio.2016.03.006

M3 - Article

AN - SCOPUS:84962873386

SN - 0955-2863

VL - 32

SP - 142

EP - 150

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

ER -

Ripken D, van der Wielen N, Wortelboer HM, Meijerink J, Witkamp RF, Hendriks HFJ. Nutrient-induced glucagon like peptide-1 release is modulated by serotonin. Journal of Nutritional Biochemistry. 2016;32:142-150. doi: 10.1016/j.jnutbio.2016.03.006

Nutrient-induced glucagon like peptide-1 release is modulated by serotonin (2024)

FAQs

What stimulates glucagon-like peptide 1? ›

GLP-1 is released in response to intestinal luminal nutrients and/or bile acids and in response to submucosal neural stimulation mediated by voltage-gated Ca+2 channels. Concentrations are at their lowest levels after an overnight fast and increase upon meal ingestion in a biphasic pattern.

Does GLP-1 increase serotonin? ›

Central acute GLP-1R activation resulted in increased serotonin turnover and increased expression of several serotonin receptors in the amygdala.

How does glucagon-like peptide 1 affect the brain? ›

In recent years, studies have described a central role for GLP-1 in regulating food intake, providing neuroprotection, decreasing neuroinflammation, amplifying signal transduction, and potentiating cognitive function by counteracting learning dysregulation (3, 5, 24).

How does GLP-1 affect mental health? ›

As GLP-1 receptor agonists continue to rise in demand, adverse psychological effects, including suicidality and depression, have been reported among patients, prompting increased awareness and monitoring from several agencies, including the FDA.

What foods are high in GLP-1? ›

These are found in foods such as eggs, high fiber grains, nuts, and avocados. GLP-1 plays an important role in regulating blood sugar levels. It does this by stimulating the release of insulin from the pancreas and blocking the release of glucagon, another hormone that raises blood sugar levels.

How to get GLP-1 naturally? ›

Eating more fiber, lean protein, healthy fat, and water-rich fruits and vegetables can increase GLP-1 naturally and help with weight loss. Some small studies show that certain supplements — like berberine, curcumin, and ginseng — boost GLP-1 levels.

Can serotonin help you lose weight? ›

With plenty of serotonin in the brain, people don't have much desire for carbohydrates and don't eat as much, so they lose weight.

Does caffeine increase GLP-1? ›

Indeed, there is recent evidence that coffee increases production of the incretin hormone glucagon-like peptide-1 (GLP-1), possibly owing to an inhibitory effect of chlorogenic acid (CGA – the chief polyphenol in coffee) on glucose absorption.

What triggers GLP-1 release? ›

Orally-consumed carbohydrates, proteins, and lipids induce the secretion of GLP-1 from intestinal L-cells; however, GLP-1-mediated stimulation of insulin secretion from β-cells is only observed in the presence of elevated glucose concentrations.

What are the adverse effects of glucagon like peptide 1? ›

Some of the more common side effects include:
  • Nausea.
  • Vomiting.
  • Diarrhea.

Which medicine is glucagon like peptide 1? ›

GLP-1 agonists are medications that help lower blood sugar levels and promote weight loss. There are many different types. And they're just one part of your treatment plan if you have Type 2 diabetes or obesity. Your healthcare provider can help you decide if they're right for you.

What are the symptoms of GLP-1 deficiency? ›

Deficiencies can arise during weight loss efforts due to changes in dietary intake, nutrient absorption, and metabolic demands, leading to symptoms such as fatigue, weakness, and cognitive impairment.

Does GLP-1 help with anxiety? ›

On Tuesday, February 6, 2024, Epic Research published the results of a dual-team Cosmos study, highlighting that taking certain glucagon-like peptide-1 (GLP-1) receptor agonists may reduce the chances of an anxiety or depression diagnosis.

Do all GLP-1 cause weight loss? ›

5 Clinical effects on weight of GLP-based therapy

Hence GLP-1 therapy in humans reduces food intake, appetite and hunger and promotes fullness and satiety with the ultimate result of promoting weight loss.

Does GLP-1 give you energy? ›

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

What triggers a GLP-1 release? ›

Orally-consumed carbohydrates, proteins, and lipids induce the secretion of GLP-1 from intestinal L-cells; however, GLP-1-mediated stimulation of insulin secretion from β-cells is only observed in the presence of elevated glucose concentrations.

How to get GLP-1? ›

You need a prescription from a doctor to buy GLP-1s online. To qualify for a GLP-1 medication, you'll need to have a consultation with a physician who must prescribe the medication for you. The FDA has approved some GLP-1 drugs for people with type 2 diabetes only.

What are GPL1 medications? ›

GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonists are most often injectable medications, meaning you inject a liquid medication with a needle and syringe.

Where does glucagon-like peptide-1 come from? ›

It is produced and secreted by intestinal enteroendocrine L-cells and certain neurons within the nucleus of the solitary tract in the brainstem upon food consumption.

Top Articles
Latest Posts
Article information

Author: Msgr. Refugio Daniel

Last Updated:

Views: 5367

Rating: 4.3 / 5 (54 voted)

Reviews: 85% of readers found this page helpful

Author information

Name: Msgr. Refugio Daniel

Birthday: 1999-09-15

Address: 8416 Beatty Center, Derekfort, VA 72092-0500

Phone: +6838967160603

Job: Mining Executive

Hobby: Woodworking, Knitting, Fishing, Coffee roasting, Kayaking, Horseback riding, Kite flying

Introduction: My name is Msgr. Refugio Daniel, I am a fine, precious, encouraging, calm, glamorous, vivacious, friendly person who loves writing and wants to share my knowledge and understanding with you.